Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI

University of British Columbia

$24,906.00

The Vaginal Microbiome Team For Reproductive Health Care and Knowledge Translation

FY 2018-19

Summary
Research that focuses on improving women's reproductive healthcare is of huge importance due to the lifelong influence of childbirth and reproduction on both women and their infants. Our research team is poised to use and advance our knowledge of the normal bacteria that naturally live in the vagina (the vaginal microbiome) to tailor diagnosis, treatment, and knowledge sharing in women's reproductive health. We will target two areas affecting millions of women in Canada each year, the eradication of cervical cancer and the reduction in unnecessary antibiotic use in childbirth whilst reducing post birth infections in women. Cervical cancer screening currently lacks the ability to fully define a woman's risk for progression to cervical cancer. By evaluating the bacterial and viral populations that live in the vagina we will be able to group women into high and low risk of developing cervical cancer. Thus reducing the number of inappropriate and stressful investigations and saving lives of women at high risk of developing cervical cancer. Over 400,000 babies are born in Canada each year and childbirth complication including infection continue to influence both maternal and infant health. Use of antibiotics has proven to be lifesaving for mom and infant, but is not personalized or tailored and there is growing concern about overuse of antibiotics and its long-term effects on health. Thus, the evaluation of the role of the vaginal micro-organisms and proteins in development of infections after childbirth is key for both improvement of maternal and infant health. The output from these studies are very complex and we need to develop clear and simplified methods to visualize this information. Our team has a plan to create new visualization methods to make this effective. We will share this with clinicians and women to determine how to best do this research and to share the results clearly and simply.
Program
Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
399161
Name
Money Deborah M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Team Grant : Canadian Microbiome Initiative 2: Research Teams
Projecttitle
The Vaginal Microbiome Team For Reproductive Health Care and Knowledge Translation
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$24,906
Cihrequipment2
$0
Programname2
Team Grant: Canadian Microbiome Initiative 2: Research Teams - LOI
Keyworddelim
Cervical Cancer; Hpv; Maternal And Infant Microbiome; Proteomics; Reproductive Health; Women'S Precision Medicine
Abstract
Research that focuses on improving women's reproductive healthcare is of huge importance due to the lifelong influence of childbirth and reproduction on both women and their infants. Our research team is poised to use and advance our knowledge of the normal bacteria that naturally live in the vagina (the vaginal microbiome) to tailor diagnosis, treatment, and knowledge sharing in women's reproductive health. We will target two areas affecting millions of women in Canada each year, the eradication of cervical cancer and the reduction in unnecessary antibiotic use in childbirth whilst reducing post birth infections in women. Cervical cancer screening currently lacks the ability to fully define a woman's risk for progression to cervical cancer. By evaluating the bacterial and viral populations that live in the vagina we will be able to group women into high and low risk of developing cervical cancer. Thus reducing the number of inappropriate and stressful investigations and saving lives of women at high risk of developing cervical cancer. Over 400,000 babies are born in Canada each year and childbirth complication including infection continue to influence both maternal and infant health. Use of antibiotics has proven to be lifesaving for mom and infant, but is not personalized or tailored and there is growing concern about overuse of antibiotics and its long-term effects on health. Thus, the evaluation of the role of the vaginal micro-organisms and proteins in development of infections after childbirth is key for both improvement of maternal and infant health. The output from these studies are very complex and we need to develop clear and simplified methods to visualize this information. Our team has a plan to create new visualization methods to make this effective. We will share this with clinicians and women to determine how to best do this research and to share the results clearly and simply.
Competitiondate
201811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Money, Deborah M; Elwood, Chelsea; Hill, Janet E; Mitchell-Foster, Sheona; O'Doherty, Kieran C; Ogilvie, Gina S
Approvedterm
1 an 0 mois
Cihrcontribution2
HIV/AIDS~ $24,906~ $0~